Impact of hypnosis during embryo transfer on the outcome of in vitro fertilization-embryo transfer: a case-control study.
OBJECTIVE
To investigate whether hypnosis during ET contributes to successful IVF/ET outcome.


METHODS
Case-control clinical study.


METHODS
Academic Fertility and IVF Unit, Soroka Medical Center, Beer-Sheva, Israel.


METHODS
Infertile couples undergoing IVF.


METHODS
Ninety-eight IVF/ET cycles with hypnosis during the ET procedure were matched with 96 regular IVF/ET cycles.


METHODS
Comparison of clinical pregnancy and implantation rates between the two groups.


RESULTS
We obtained 52 clinical pregnancies out of 98 cycles (53.1%) with an implantation rate of 28% among hypnosis IVF/ET cycles, and 29 out of 96 (30.2%) clinical pregnancies and an implantation rate of 14.4% in the control cycles. Our overall IVF program pregnancy rate for the same period was 32.1%. Logistic regression analysis was performed emphasizing the positive contribution of hypnosis to the IVF/ET conception rates.


CONCLUSIONS
This study suggests that the use of hypnosis during ET may significantly improve the IVF/ET cycle outcome in terms of increased implantation and clinical pregnancy rates. Furthermore, it seems that the patients' attitude to the treatment was more favorable.
Levitas
Eliahu
E
Fertility and IVF Unit, Soroka University Medical Center, Beer-Sheva, Israel. EliahuL@clalit.org.il
Parmet
Aldo
A
Lunenfeld
Eitan
E
Bentov
Yacov
Y
Burstein
Eliezer
E
Friger
Michael
M
Potashnik
Gad
G
D000328:Adult; D016022:Case-Control Studies; D003131:Combined Modality Therapy / Q000706:statistics & numerical data; D004624:Embryo Transfer / Q000706:statistics & numerical data*; D005260:Female; D005307:Fertilization in Vitro / Q000706:statistics & numerical data*; D006801:Humans; D006990:Hypnosis / Q000706:statistics & numerical data*; D015994:Incidence; D007246:Infertility / Q000453:epidemiology* / Q000628:therapy*; D007557:Israel / Q000453:epidemiology; D011247:Pregnancy / Q000706:statistics & numerical data; D011256:Pregnancy Outcome / Q000453:epidemiology*; D018873:Pregnancy Rate; D011994:Recombinant Proteins / Q000008:administration & dosage; D016896:Treatment Outcome
D011994:Recombinant Proteins